Collegium Pharmaceutical, Inc. COLL Segment — Intangible asset amortization
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Collegium Pharmaceutical, Inc. in its filing.
Tagged under the XBRL concept coll:AmortizationAndImpairmentOfIntangibleAssets.
The official record: Collegium Pharmaceutical, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Collegium Pharmaceutical, Inc.'s segment — intangible asset amortization.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Collegium Pharmaceutical, Inc.'s segment — intangible asset amortization?
- Collegium Pharmaceutical, Inc. (COLL) reported segment — intangible asset amortization of $55.47M in Q1 2026.
- How has Collegium Pharmaceutical, Inc.'s segment — intangible asset amortization changed year-over-year?
- Collegium Pharmaceutical, Inc.'s segment — intangible asset amortization decreased by 0.0% year-over-year, from $55.47M to $55.47M.
- What is the long-term trend for Collegium Pharmaceutical, Inc.'s segment — intangible asset amortization?
- Over 2 years (2022 to 2024), Collegium Pharmaceutical, Inc.'s segment — intangible asset amortization has grown at a 10.1% compound annual growth rate (CAGR), from $136.26M to $165.3M.
- What does segment — intangible asset amortization mean?
- Reflects the periodic non-cash expense related to the allocation of the cost of acquired intangible assets, such as patents and product rights, over their useful lives. Monitoring this helps investors understand the impact of past acquisitions on current reported earnings.